Phase II study of durvalumab alone or in combination with ADXS11-001 (AXAL) in recurrent/persistent or metastatic cervical cancer

Phase II study of durvalumab alone or in combination with ADXS11-001 (AXAL) in recurrent/persistent or metastatic cervical cancer

Saved in:
Bibliographic Details
Published in:Gynecologic oncology Vol. 159; pp. 4 - 5
Main Authors: Slomovitz, B., Bradley, W.H., Ghamande, S., O'Malley, D.M., Huang, M., Chon, H.S., Vangala, S., Sheeri, S., Gutierrez, A.A., Moore, K.N.
Format: Journal Article
Language:English
Published: Elsevier Inc 01-10-2020
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0090-8258
1095-6859
DOI:10.1016/j.ygyno.2020.06.008